$TLYS
TILLY'S, INC.

2021 Q4 Form 10-Q Financial Statement

#000162828021024634 Filed on December 07, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q4
Revenue $206.1M $202.0M $140.3M
YoY Change 46.92% 48.66% -9.37%
Cost Of Revenue $129.4M $127.2M $99.62M
YoY Change 29.86% 35.1% -7.43%
Gross Profit $76.74M $74.73M $40.66M
YoY Change 88.73% 79.31% -13.8%
Gross Profit Margin 37.23% 37.0% 28.99%
Selling, General & Admin $47.74M $48.30M $37.12M
YoY Change 28.61% 42.21% -5.94%
% of Gross Profit 62.21% 64.64% 91.3%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $4.314M $4.485M $4.580M
YoY Change -5.81% -9.76% -9.13%
% of Gross Profit 5.62% 6.0% 11.26%
Operating Expenses $47.74M $48.30M $37.12M
YoY Change 28.61% 42.21% -5.94%
Operating Profit $29.00M $26.43M $3.538M
YoY Change 719.59% 242.81% -54.08%
Interest Expense $19.00K $43.00K $0.00
YoY Change -85.67%
% of Operating Profit 0.07% 0.16% 0.0%
Other Income/Expense, Net -$1.000K -$102.0K -$28.00K
YoY Change -96.43% -132.8% -103.07%
Pretax Income $29.00M $26.33M $3.510M
YoY Change 726.1% 228.24% -59.26%
Income Tax $8.162M $5.927M $1.397M
% Of Pretax Income 28.15% 22.51% 39.8%
Net Earnings $20.83M $20.40M $2.113M
YoY Change 885.99% 287.35% -66.92%
Net Earnings / Revenue 10.11% 10.1% 1.51%
Basic Earnings Per Share $0.07
Diluted Earnings Per Share $664.5K $655.6K $0.07
COMMON SHARES
Basic Shares Outstanding 30.92M shares 30.50M shares 29.71M shares
Diluted Shares Outstanding 31.35M shares 31.11M shares 29.81M shares

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $155.6M $148.5M $125.3M
YoY Change 24.23% -0.25% -3.57%
Cash & Equivalents $59.39M $81.89M $99.31M
Short-Term Investments $96.24M $66.63M $25.96M
Other Short-Term Assets $9.926M $7.810M $5.600M
YoY Change 77.25% 95.25% -13.85%
Inventory $86.69M $86.85M $65.94M
Prepaid Expenses
Receivables $8.881M $13.14M $11.40M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $261.1M $256.3M $208.2M
YoY Change 25.43% 9.45% -3.6%
LONG-TERM ASSETS
Property, Plant & Equipment $49.39M $51.17M $54.76M
YoY Change -9.8% -9.92% -22.41%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $13.17M $11.60M $9.150M
YoY Change 43.93% 37.16% 262.95%
Total Long-Term Assets $289.1M $278.8M $300.3M
YoY Change -3.74% -10.14% -8.67%
TOTAL ASSETS
Total Short-Term Assets $261.1M $256.3M $208.2M
Total Long-Term Assets $289.1M $278.8M $300.3M
Total Assets $550.2M $535.2M $508.5M
YoY Change 8.2% -1.71% -6.66%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $46.38M $59.05M $36.25M
YoY Change 27.96% 21.23% -3.25%
Accrued Expenses $20.08M $23.90M $21.98M
YoY Change -8.64% 23.08% 12.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $152.2M $166.5M $142.4M
YoY Change 6.83% -3.71% 11.75%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.112M $1.385M $838.0K
YoY Change 32.7% 46.72% -11.04%
Total Long-Term Liabilities $1.112M $1.385M $838.0K
YoY Change 32.7% 46.72% -11.04%
TOTAL LIABILITIES
Total Short-Term Liabilities $152.2M $166.5M $142.4M
Total Long-Term Liabilities $1.112M $1.385M $838.0K
Total Liabilities $357.6M $363.9M $357.3M
YoY Change 0.08% -8.08% -1.64%
SHAREHOLDERS EQUITY
Retained Earnings $26.62M $5.782M -$3.736M
YoY Change -812.42% -198.85% -112.59%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $192.6M $171.2M $151.2M
YoY Change
Total Liabilities & Shareholders Equity $550.2M $535.2M $508.5M
YoY Change 8.2% -1.71% -6.66%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q4
OPERATING ACTIVITIES
Net Income $20.83M $20.40M $2.113M
YoY Change 885.99% 287.35% -66.92%
Depreciation, Depletion And Amortization $4.314M $4.485M $4.580M
YoY Change -5.81% -9.76% -9.13%
Cash From Operating Activities $9.408M $18.17M $2.190M
YoY Change 329.59% -52.71% -78.96%
INVESTING ACTIVITIES
Capital Expenditures -$2.400M -$3.019M -$2.150M
YoY Change 11.63% 331.29% -62.87%
Acquisitions
YoY Change
Other Investing Activities -$29.56M $10.02M -$10.02M
YoY Change 195.05% -66.74% -3332.26%
Cash From Investing Activities -$31.96M $7.000M -$12.16M
YoY Change 162.86% -76.21% 122.3%
FINANCING ACTIVITIES
Cash Dividend Paid $30.90M $30.70M
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 54.00K -24.29M -23.68M
YoY Change -100.23% -9207.69%
NET CHANGE
Cash From Operating Activities 9.408M 18.17M 2.190M
Cash From Investing Activities -31.96M 7.000M -12.16M
Cash From Financing Activities 54.00K -24.29M -23.68M
Net Change In Cash -22.50M 879.0K -33.65M
YoY Change -33.13% -98.7% -747.12%
FREE CASH FLOW
Cash From Operating Activities $9.408M $18.17M $2.190M
Capital Expenditures -$2.400M -$3.019M -$2.150M
Free Cash Flow $11.81M $21.18M $4.340M
YoY Change 172.07% -45.83% -73.21%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
30682000 USD
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
21984000 USD
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
13568000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9899000 USD
CY2021Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
13492000 USD
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
11051000 USD
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
17106000 USD
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0001524025
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-29
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-10-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35535
dei Entity Registrant Name
EntityRegistrantName
TILLY’S, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
45-2164791
dei Entity Address Address Line1
EntityAddressAddressLine1
10 Whatney
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92618
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
609-5599
dei Security12b Title
Security12bTitle
Class A Common Stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
TLYS
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
59392000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76184000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99309000 USD
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
96237000 USD
CY2021Q1 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
64955000 USD
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
25987000 USD
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
8881000 USD
CY2021Q1 us-gaap Receivables Net Current
ReceivablesNetCurrent
8724000 USD
CY2020Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
11397000 USD
CY2021Q4 us-gaap Inventory Net
InventoryNet
86692000 USD
CY2021Q1 us-gaap Inventory Net
InventoryNet
55698000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
65936000 USD
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9926000 USD
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
6595000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
5557000 USD
CY2021Q4 us-gaap Assets Current
AssetsCurrent
261128000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
212156000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
208186000 USD
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
226547000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
229864000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
236443000 USD
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49392000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
52639000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
54756000 USD
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
13170000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12797000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
9150000 USD
CY2021Q4 us-gaap Assets
Assets
550237000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
36245000 USD
CY2021Q1 us-gaap Assets
Assets
507456000 USD
CY2020Q4 us-gaap Assets
Assets
508535000 USD
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
46378000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
24983000 USD
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
20084000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
10096000 USD
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
54299000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
54503000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
62747000 USD
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
727000 USD
CY2021Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
632000 USD
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
316000 USD
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
152162000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
134191000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
142439000 USD
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
204325000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
211292000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
214052000 USD
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1112000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1351000 USD
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
838000 USD
CY2021Q4 us-gaap Liabilities
Liabilities
357599000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
346834000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
357329000 USD
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
154894000 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
165983000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
155437000 USD
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
26616000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
5135000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3736000 USD
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8000 USD
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
20000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
18000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
192638000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
160622000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
151206000 USD
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
550237000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
507456000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
508535000 USD
CY2021Q4 us-gaap Revenues
Revenues
206096000 USD
CY2020Q4 us-gaap Revenues
Revenues
140275000 USD
us-gaap Revenues
Revenues
571205000 USD
us-gaap Revenues
Revenues
353409000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
692000 USD
CY2021Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
129357000 USD
CY2020Q4 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
99615000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
364900000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
269481000 USD
CY2021Q4 us-gaap Gross Profit
GrossProfit
76739000 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
40660000 USD
us-gaap Gross Profit
GrossProfit
206305000 USD
us-gaap Gross Profit
GrossProfit
83928000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16462000 USD
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
28996000 USD
CY2021Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
47742000 USD
CY2020Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
37122000 USD
CY2020Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3510000 USD
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8162000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
70079000 USD
CY2020Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1397000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
136007000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
101082000 USD
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
28997000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
3538000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
70298000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-17154000 USD
CY2021Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1000 USD
CY2020Q4 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-28000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-219000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-196000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17888000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-6446000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
20834000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
2113000 USD
us-gaap Net Income Loss
NetIncomeLoss
52191000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10016000 USD
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30915000 shares
CY2021Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4000 USD
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29708000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30429000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29693000 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31352000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29810000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31016000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29693000 shares
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
20834000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
2113000 USD
us-gaap Net Income Loss
NetIncomeLoss
52191000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10016000 USD
CY2021Q4 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-4000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
17000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-12000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
17000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-196000 USD
CY2021Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
20830000 USD
CY2020Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2130000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
52179000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10212000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
148568000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
171232000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
20834000 USD
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
20834000 USD
CY2021Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
521000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
55000 USD
CY2020Q4 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
17000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
2113000 USD
CY2020Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
508000 USD
CY2021Q4 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-4000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
192638000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
151206000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
160622000 USD
us-gaap Net Income Loss
NetIncomeLoss
52191000 USD
us-gaap Net Income Loss
NetIncomeLoss
52191000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
30710000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1417000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9130000 USD
us-gaap Proceeds From Insurance Settlement Operating Activities
ProceedsFromInsuranceSettlementOperatingActivities
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1417000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-52000 USD
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-67000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1517000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-12000 USD
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
192638000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
159901000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10016000 USD
us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
51000 shares
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1517000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-196000 USD
us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-196000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
151206000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
136000 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
929000 USD
us-gaap Net Income Loss
NetIncomeLoss
52191000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10016000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
13123000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
14571000 USD
CY2021Q4 us-gaap Proceeds From Insurance Settlement Operating Activities
ProceedsFromInsuranceSettlementOperatingActivities
117000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
101000 USD
us-gaap Gain Loss On Investments
GainLossOnInvestments
685000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
16130000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
57000 USD
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1142000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-1847000 USD
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
3912000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
31111000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
9035000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3698000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1912000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
21402000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-9804000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
2392000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
76000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-710000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
7207000 USD
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2906000 USD
tlys Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-5205000 USD
tlys Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
6224000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-115000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-856000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
37816000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
46850000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21033000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10911000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6395000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
17000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
23675000 USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 USD
us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
29000 USD
us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
126420000 USD
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
30946000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
95224000 USD
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
75157000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-42061000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
23675000 USD
CY2021Q4 us-gaap Number Of Stores
NumberOfStores
243 store
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
857000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1702000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2246000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
29677000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9129000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
11999 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-21581000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
32787 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-29677000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16792000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
29172000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
76184000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70137000 USD
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59392000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99309000 USD
us-gaap Interest Paid Net
InterestPaidNet
0 USD
us-gaap Interest Paid Net
InterestPaidNet
182000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
26493000 USD
CY2021Q4 tlys Number Of States
NumberOfStates
33 State
CY2021Q4 us-gaap Fiscal Period
FiscalPeriod
<div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal Periods</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year ends on the Saturday closest to January 31. References to fiscal 2021 refer to the fiscal year ending January 29,<br/>2022. References to the fiscal quarters or first nine months ended October 30, 2021 and October 31, 2020 refer to the thirteen and thirty-nine week periods ended as of those dates, respectively.</span></div>
CY2021Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
96226000 USD
CY2021Q4 us-gaap Revenues
Revenues
206096000 USD
CY2020Q4 us-gaap Revenues
Revenues
140275000 USD
us-gaap Revenues
Revenues
571205000 USD
CY2021Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
96237000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
64928000 USD
us-gaap Revenues
Revenues
353409000 USD
CY2021Q4 tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
CY2020Q4 tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
CY2021Q4 tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
CY2020Q4 tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
tlys Percentage Of Total Net Sales
PercentageOfTotalNetSales
1
CY2021Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
2300000 USD
CY2021Q1 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1400000 USD
CY2020Q4 us-gaap Valuation Allowances And Reserves Balance
ValuationAllowancesAndReservesBalance
1500000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
4000000 USD
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
3700000 USD
tlys Unredeemed Awardsand Accumulated Points Expiration Period
UnredeemedAwardsandAccumulatedPointsExpirationPeriod
P365D
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
5700000 USD
CY2021Q1 us-gaap Deferred Revenue
DeferredRevenue
3900000 USD
CY2020Q4 us-gaap Deferred Revenue
DeferredRevenue
3600000 USD
CY2021Q4 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
2800000 USD
CY2020Q4 us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
1900000 USD
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
7700000 USD
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
4200000 USD
CY2021Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P10Y
CY2021Q4 tlys Number Of Stores Covid Lease Not Yet Negotiated
NumberOfStoresCOVIDLeaseNotYetNegotiated
10
CY2021Q4 tlys Operating Lease Withheld Lease Payments
OperatingLeaseWithheldLeasePayments
400000 USD
CY2021Q4 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P10Y
CY2021Q4 us-gaap Lessee Operating Lease Renewal Term
LesseeOperatingLeaseRenewalTerm
P10Y
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
17703000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
67168000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
56627000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
46210000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
37160000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
82697000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
307565000 USD
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
48941000 USD
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
258624000 USD
CY2021Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
15413000 USD
CY2020Q4 us-gaap Operating Lease Cost
OperatingLeaseCost
15238000 USD
CY2021Q4 us-gaap Variable Lease Cost
VariableLeaseCost
4922000 USD
CY2020Q4 us-gaap Variable Lease Cost
VariableLeaseCost
4675000 USD
CY2021Q4 us-gaap Lease Cost
LeaseCost
20335000 USD
CY2020Q4 us-gaap Lease Cost
LeaseCost
19913000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
46295000 USD
us-gaap Operating Lease Cost
OperatingLeaseCost
46441000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
13658000 USD
us-gaap Variable Lease Cost
VariableLeaseCost
12969000 USD
us-gaap Lease Cost
LeaseCost
59953000 USD
us-gaap Lease Cost
LeaseCost
59410000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
12000 USD
CY2021Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
51823000 USD
us-gaap Operating Lease Payments
OperatingLeasePayments
36694000 USD
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y7M6D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y9M18D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0616
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0464
tlys Income Tax Expense Benefit Narrative
IncomeTaxExpenseBenefitNarrative
17900000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.255
tlys Income Tax Expense Benefit Narrative
IncomeTaxExpenseBenefitNarrative
-6400000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.392
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
1000000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
28000 USD
CY2021Q1 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1000 USD
CY2021Q1 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
64955000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
25962000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
25000 USD
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
25987000 USD
CY2021Q2 us-gaap Dividends Common Stock
DividendsCommonStock
31000000 USD
CY2021Q2 us-gaap Payments Of Dividends
PaymentsOfDividends
30700000 USD
CY2020Q4 us-gaap Line Of Credit
LineOfCredit
23700000 USD
tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
1 store
us-gaap Asset Impairment Charges
AssetImpairmentCharges
100000 USD
CY2020Q4 tlys Impaired Long Lived Assets Heldand Used Carrying Amount
ImpairedLongLivedAssetsHeldandUsedCarryingAmount
26000 USD
tlys Impaired Long Lived Assets Heldand Used Carrying Amount
ImpairedLongLivedAssetsHeldandUsedCarryingAmount
176000 USD
tlys Impaired Long Lived Assets Heldand Used Carrying Amount
ImpairedLongLivedAssetsHeldandUsedCarryingAmount
929000 USD
CY2020Q4 tlys Impaired Long Lived Assets Heldand Used Fair Value
ImpairedLongLivedAssetsHeldandUsedFairValue
0 USD
tlys Impaired Long Lived Assets Heldand Used Fair Value
ImpairedLongLivedAssetsHeldandUsedFairValue
40000 USD
tlys Impaired Long Lived Assets Heldand Used Fair Value
ImpairedLongLivedAssetsHeldandUsedFairValue
0 USD
CY2021Q4 tlys Numberof Stores Testedfor Impairment
NumberofStoresTestedforImpairment
1 store
CY2020Q4 tlys Numberof Stores Testedfor Impairment
NumberofStoresTestedforImpairment
34 store
tlys Numberof Stores Testedfor Impairment
NumberofStoresTestedforImpairment
12 store
tlys Numberof Stores Testedfor Impairment
NumberofStoresTestedforImpairment
52 store
CY2021Q4 tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
0 store
CY2020Q4 tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
2 store
tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
1 store
tlys Numberof Storeswith Impairment
NumberofStoreswithImpairment
12 store
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2602212 shares
CY2021Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
7.86
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.19
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
513700 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
10.84
CY2021Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1161571 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
273479 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
9.24
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
32000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
16.26
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1648862 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
8.91
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y7M6D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8383000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
486792 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.50
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y9M18D
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1844000 USD
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.96
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.04
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.69
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.19
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y3M18D
CY2020Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y8M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y4M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y3M18D
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.594
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.599
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.575
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.010
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.003
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.599
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.009
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.004
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q4 us-gaap Share Based Compensation
ShareBasedCompensation
521000 USD
CY2020Q4 us-gaap Share Based Compensation
ShareBasedCompensation
508000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1417000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1517000 USD
CY2021Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
4400000 USD
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y8M12D
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
20834000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
2113000 USD
us-gaap Net Income Loss
NetIncomeLoss
52191000 USD
us-gaap Net Income Loss
NetIncomeLoss
-10016000 USD
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30915000 shares
CY2020Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29708000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30429000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29693000 shares
CY2021Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
437000 shares
CY2020Q4 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
102000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
587000 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31352000 shares
CY2020Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29810000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31016000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29693000 shares
CY2021Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
677000 shares
CY2020Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1503000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
820000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2669000 shares

Files In Submission

Name View Source Status
0001628280-21-024634-index-headers.html Edgar Link pending
0001628280-21-024634-index.html Edgar Link pending
0001628280-21-024634.txt Edgar Link pending
0001628280-21-024634-xbrl.zip Edgar Link pending
exhibit10117pasteurfirstam.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
q32021ex311.htm Edgar Link pending
q32021ex312.htm Edgar Link pending
q32021ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tlys-20211030.htm Edgar Link pending
tlys-20211030.xsd Edgar Link pending
tlys-20211030_cal.xml Edgar Link unprocessable
tlys-20211030_def.xml Edgar Link unprocessable
tlys-20211030_htm.xml Edgar Link completed
tlys-20211030_lab.xml Edgar Link unprocessable
tlys-20211030_pre.xml Edgar Link unprocessable